Literature DB >> 29063980

Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review.

Yu-Wen Lan1,2,3, Jui-Wen Hsieh4,5,6.   

Abstract

PURPOSE: To report two cases of ciliochoroidal effusion after the usage of topiramate. CASES: Two middle-aged women experienced sudden onset of acute glaucoma and acquired myopia after taking topiramate. Ultrasound biomicroscopy demonstrated bilateral ciliochoroidal effusion and angle closure. The A-scan ultrasonography revealed shallow anterior chamber and thick lens. After the treatment and drug withdrawal, intraocular pressure, refractive status and angle anatomy returned to normal and there was resolution of ciliochoroidal effusion. During the clinical course, the anterior chamber depth (ACD) increased from 2.02 to 3.30 mm (1.28 mm of changes) OD and from 1.94 to 3.36 mm (1.42 mm of changes) OS. The lens thickness (LT) became thinner from 4.53 to 4.31 mm (0.22 mm of changes) OD and from 4.59 to 4.30 mm (0.29 mm of changes) OS in the first case. In the second case, the ACD increased from 2.33 to 3.07 mm (0.74 mm of changes) OD and from 2.30 to 3.05 mm (0.75 mm of changes) OS. The LT became thinner from 4.42 to 4.27 mm (0.15 mm of changes) OD and from 4.38 to 4.26 mm (0.12 mm of changes) OS. The forward displacement of the lens-iris diaphragm contributed more to the shallowness of the anterior chamber than the thickening of the lens itself (only accounting for 20%).
CONCLUSION: Topiramate-induced bilateral acute angle closure glaucoma and myopic shift was due to ciliochoroidal effusion which resulted in thicker lens and shallow anterior chamber. The later was mainly due to anterior displacement of the lens-iris diaphragm.

Entities:  

Keywords:  Acute angle closure glaucoma; Ciliochoroidal effusion; Myopic shift; Topiramate

Mesh:

Substances:

Year:  2017        PMID: 29063980     DOI: 10.1007/s10792-017-0740-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  43 in total

1.  Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects.

Authors:  F W Fraunfelder; F T Fraunfelder
Journal:  Ophthalmology       Date:  2004-07       Impact factor: 12.079

Review 2.  New and future migraine therapy.

Authors:  Nabih M Ramadan; Thomas M Buchanan
Journal:  Pharmacol Ther       Date:  2006-06-23       Impact factor: 12.310

3.  The occurrence of drug-induced myopia as a transient side effect of topiramate.

Authors:  S S Gubbay
Journal:  Epilepsia       Date:  1998-04       Impact factor: 5.864

4.  Topiramate-induced acute bilateral angle closure and myopia: pathophysiology and treatment controversies.

Authors:  Christopher van Issum; Nikolaos Mavrakanas; James S Schutz; Tarek Shaarawy
Journal:  Eur J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 2.597

Review 5.  Angle closure glaucoma: a mechanistic review.

Authors:  Monisha E Nongpiur; Judy Y F Ku; Tin Aung
Journal:  Curr Opin Ophthalmol       Date:  2011-03       Impact factor: 3.761

Review 6.  Pharmacological and environmental factors in primary angle-closure glaucoma.

Authors:  Ian Subak-Sharpe; Sancy Low; Winifred Nolan; Paul J Foster
Journal:  Br Med Bull       Date:  2009-11-17       Impact factor: 4.291

7.  Choroidal drainage in the management of acute angle closure after topiramate toxicity.

Authors:  Rajul Parikh; Shefali Parikh; Sanghamitra Das; Ravi Thomas
Journal:  J Glaucoma       Date:  2007-12       Impact factor: 2.503

Review 8.  The effect of antiepileptic drugs on visual performance.

Authors:  Emma J Roff Hilton; Sarah L Hosking; Tim Betts
Journal:  Seizure       Date:  2004-03       Impact factor: 3.184

9.  Refractory topiramate-induced angle-closure glaucoma in a man: a case report.

Authors:  Matthew C Willett; Deepak P Edward
Journal:  J Med Case Rep       Date:  2011-01-26

10.  Topiramate-associated bilateral anterior uveitis and angle closure glaucoma.

Authors:  Nibedita Acharya; Suneetha Nithyanandam; Sripathi Kamat
Journal:  Indian J Ophthalmol       Date:  2010 Nov-Dec       Impact factor: 1.848

View more
  4 in total

Review 1.  A review of systemic medications that may modulate the risk of glaucoma.

Authors:  Annie Wu; Anthony P Khawaja; Louis R Pasquale; Joshua D Stein
Journal:  Eye (Lond)       Date:  2019-10-08       Impact factor: 3.775

2.  Topiramate-induced angle closure glaucoma: Two unique case reports.

Authors:  Nouf A Alzendi; Abdulrahman H Badawi; Bader Alhazzaa; Ali Alshahrani; Ohoud Owaidhah
Journal:  Saudi J Ophthalmol       Date:  2021-02-27

Review 3.  Topiramate-induced acute angle closure: A systematic review of case reports and case series.

Authors:  Adi Mohammed Al Owaifeer; Zahra Mohammed AlSultan; Abdulrahman H Badawi
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

Review 4.  The Ophthalmic Side Effects of Topiramate: A Review.

Authors:  Monia Mechrgui; Suleman Kanani
Journal:  Cureus       Date:  2022-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.